Multiple myeloma with unusual inclusions
Mycobacterium kansasii in a patient with hairy cell leukaemia
Large-scale blood group genotyping – clinical implications
An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma : state of the science
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators
Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia
Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma : incidence and survival in the United States, 1992–2004
Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)
Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue
Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome
A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene
A substrate peptide for the FLT3 receptor tyrosine kinase
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia
Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy – results from a single UK centre
Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation
MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma
CSF3R mutations in paediatric acute myeloid leukaemia
Dilemmas in the Diagnosis and Management of Lymphoma